glp-1 patch vs shot A Boston startup wants to turn weight loss therapy into a once-weekly patch. No syringe, no refrigerator. They just raised $12.6M to do it. The weekly weight-loss might be losing Your Options for GLP-1 Delivery

Endoplasmic reticulum stress in liver diseases

A 2018 review article published in the World Journal of Mens Health noted that decreased secretion of DHEA may be a risk factor for erectile dysfunction

Plasma from blood samples (50 L) collected between the 10 and 20-min time point was isolated by centrifugation at 17,000 g for 10 min at 4 C and stored at 20 C until analysis

Salari N, Kanjoori AH, Hosseinian-Far A, Hasheminezhad R, Mansouri K, Mohammadi M

Novo Nordisks Wegovy (semaglutide), the first and only once-weekly GLP-1 receptor agonist approved for weight management in people with obesity, has been found to help patients lose up to 15 percent of their body weight in over 68 weeks